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Abstract We produced a model of  orthotopic trans- 
plantation in C3H/He mice by transplanting MBT-2 
cells. A single-cell suspension of  1.0 × 105 MBT-2 cells/ 
0.02 ml was successfully injected into the submucosal 
layer of  the bladder, with an incidence of 100% after 
four experimental weeks. Inoculated tumor grew ex- 
pansively into the bladder cavity from the bladder sub- 
mucosa and invaded the serosa and the surrounding 
tissue. This model more closely resembled the charac- 
teristics of  human bladder tumor when compared to 
other bladder cancer models. The results of  the histo- 
logical observation, electron microscopic examination 
and DNA content analysis by flow cytometry showed 
that the transplanted carcinoma maintained the biologic 
characteristics of  the pr imary tumor. 
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Introduction 
The orthotopic murine bladder tumor is an invaluable 
experimental tool for assessing potential therapeutic 
agents against bladder carcinoma. It has been used for 
evaluating intravesical therapy [bacillus calmette gu6rin 
(BCG) and interleukin-2 (IL-2) [1, 2, 7]. Soloway [9] 
has successfully established a localized transitional cell 
carcinoma model in mice using intravesical instillation 
of  tumor cell suspension (MBT-2) into denuded [by 
N-methyl-N-nitrosourea (MNU)]  focally fulgurated 
bladder [9]. However, this method can only be applied 
to female mice and often produces urinary stones. The 
success rate of  the tumor implantation method varies 
between 50% and 70% [9, 10]. A study was undertaken 
to investigate the possibility of  developing a orthotopic 
tumor model in mice by injecting tumor cell suspension 
into the submucosal layer of  the bladders of  syngenic 
animals. 
Materials and methods 
Tumor cells and tumor implantation 
N-(4-(5-Nitro-2-furgl)-2-thiazolyl) formamide (FANFT)-induced 
MBT-2 transitional cell carcinoma of the bladder (originally de- 
rived by Dr. Soloway) was maintained in vivo as a solid subcuta- 
neous growing tumor by serial transplantation in syngenic C3H/He 
mice (Charles River), and in vitro in RPMI1640 medium plus 10% 
fetal calf serum. Single tumor suspension was prepared by mincing 
the tumor under sterile conditions and adding to the minced tissue 
5 ml of an enzyme cocktail containing a mixture of 1% collagenase 
(Sigma, type II), 0.01% proteinase K (Sigma) and 0.01% DNAase 
(Sigma) in Dulbecco's phosphate-buffered saline (PBS). The cells 
were than washed twice with RPMI1640 medium, resuspended to 
the required concentration. The viability was always more than 
90% by the trypan blue exclusion method. The final concentration 
of the suspension was adjusted to 5.0 x 107, 1.0 x 105 and 1.0 x 103 
cells in 0.02 ml by dilution with the 1640 medium. The operation 
was performed with the mice under general anesthesia from a single 
dose of intraperitoneal sodium phenobarbital (130 mg/kg body 
weight). The urinary bladder was exposed through a low midline 
incision, the bladder was explored for tumor, 0.02 ml tumor sus- 
pension was injected into the submucosal layer of the bladders o as 
to make a "semitransparent bubble" for the submucosal layer tu- 
mor model, then omentum was drawn over the operation area. The 
procedure took place under clean but not sterile conditions and was 
performed without a magnifying lass. Animals were placed on 
antibiotics (tetracycline, 250 mg/500 ml drinking water) for 5 days 
after the operation. 
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Experimental groups 
An intermediate dosis of tumor cells (1.0 x 105 viable cells in 
0.02 ml) was injected into 48 mice. These mice were randomized 
into six groups (n - 8 each). The animals were inspected for: 
(a) weight loss, (b) the time of the appearance of the tumor and 
(c) palpation of the suprapubic mass. Mice of groups 1-5 were 
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sacrificed at 1, 2, 3, 4 and 5 weeks post-tumor implant, respectively. 
The sixth group was used as a group for observation ofthe survival 
time of the tumor-bearing animals. The large dose of tumor cells 
(5.0 x 107 cells in 0.02 ml) and the small dose of tumor cells 
(1.0 × 10 3 cells in 0.02 ml) was injected into 20 mice each in order 
to demonstrate the relationship between the time of the appearance 
and the number of the injected cells. An additional ten normal mice 
injected with 0.02 ml RPMI1640 medium were used as normal 
control group. For pathological and histological examination, 
cystectomy was performed via a midline incision after the bladder 
was distended with 0.1 ml formalin and the urethra ligated at the 
bladder neck. Tumor incidence and tumor weight were determined. 
Tumor weight was expected to be similar to the weight of a neo- 
plastic bladder. Histological examination was performed with he- 
matoxylin and eosin (H&E) staining on fixed whole bladder 
sections from the cystectomy specimens. The bladders were care- 
fully inspected for: (a) tumor incidence and (b) histological grade. 
Other organs were examined for gross abnormalities, and the 
kidneys, lungs, liver, uterus, spleen and pancreas were routinely 
processed for histology. 
A fragment of the grade II tumors from group 5 was fixed in 
3% glutaraldehyde and then postfixed in OsO4, dehydrated in 
graded alcohol and embedded inEpon 812 (Carl Roth, Karlsruhe). 
Ultrathin sections were prepared with diamond knives, stained with 
uranyl acetate and lead citrate, and viewed with an H-600 electron 
microscope. A 4 x 4-mm piece of the grade II bladder tumor from 
group 5 was minced and stored frozen at -80°C in a solution of 5% 
dimethylsulfoxide, 250 mm sucrose and 40 mm trisodium citrate 
until analysis. The tissue was minced into pieces approximately 
l mm in diameter and subsequently enzymatically dissociated using 
collagenase type (200 U/ml) and DNAse (500 K units U/ml) at 
37°C. DNA histogram display and analysis was performed on a 
Terak 8600 minicomputer (Terak, Scottsdale, AZ). Full bright 
fluorescent microspheres (Lot 5325, Coulter Electronics) were used 
to aid instrument alignment, and as an external f uorescence stan- 
dard. Murine peripheral blood mononuclear cells were used as an 
internal reference standard for DNA ploidy analysis. The cells were 
aliquoted, frozen as above and stained in parallel with the urinary 
bladder specimens in each flow cytometry run. An aneuploid 
population was considered present only if unequivocal Go/GI 
populations were evident. 
Results 
General 
The mice that received the middle cell doses all had 
palpable pubic mass-like soybean at 3 weeks, and half of 
them had gross hematur ia and were fatigued at 3-4 
weeks. At 5 weeks, all of them appeared mor ibund and 
mean weights of the mice were 13.8 ± 1.8 g, whereas 
mice of the control group had a mean weight of 
Table 1 Reduction of tumor growth with implantation f 1.0 x 10 s 
tumor cells 
Groups No. of No. of Tumor Mean Mean 
mice dead incidence bladder mouse 
mice (%) weight (g) weight (g) 
1 8 0 0.0 19.5 :t- 4.3 17.9 ± 1.6 
2 8 0 75.0 22.4 ± 20.5 17.5 ± 2.0 
3 8 0 88.0 350.0 ± 20.7 15.7 ± 2.4 
4 8 0 100.0 483.5 ± 44.5 15.4 ± 3.0 
5 8 1 100.0 510.4 ± 38.5 13.8 ± 1.8 
6 8 8 100.0 540.7 ± 40.4 12.4 ± 1.5 
Control 10 0 0.0 20.0 ± 4.7 20.2 ± 1.5 
Table 2 Effect of different numbers of the cells on the growth of 
the tumor 
Time to Tumor Mean survival 
appearance incidence time (days) 
of tumor (weeks) 
1.0 x 103 4 60.0% 58 
1.0 x 105 3 88.0% 52 
1.0 x 10 v 2 100.0% 26 
20.2 ± 1.5 g; mean bladder weight of the mice was 
510.4 ~: 38.5 mg, whereas that of the control group was 
20.0 ± 4.7 mg. At 6 weeks post-tumor implant, all mice 
died (Table 1). There was a good correlation between 
the tumor incidence and the number  of cells at 3 weeks. 
The mice injected with a small dose of MBT-2 cells had 
hematur ia t 4 weeks and the incidence of the tumor was 
60%; they survived 8 weeks after the operation. The 
mice injected with a large dose of cells had gross 
hematuria s early as 2 weeks after the procedure and all 
died at 4 weeks (Table 2). 
Pathological changes 
One week after the transplantat ion,  many vital tumor 
cells were found in the submucosa of the bladder. At 2 
weeks, the tumors were grossly visible, their surface 
appearing papil lary or nodular.  The color of the cut 
sections of these tumors was grayish (Fig. 1). After the 
3rd week, all tumors found in the bladders were large, 
occupying more than 50% of the bladder cross-sectional 
area. The tumors had hemorrhage or necrosis, and ex- 
tended into the perivesical fat or surrounding regional 
areas such as lymph nodes, mesenterium and repro- 
ductive organs. At autopsy examinat ion bilateral hydro- 
Fig. 1 The bladder partially filled with tumor at 2 weeks post-tumor 
implant; the color of the cross-section f tumor was grayish white 
Fig. 2 Bilateral hydronephrosis was observed with dead mouse at 
5 weeks post-tumor implant 
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Fig. 3 There was no specialization f the luminal membrane, and no 
zonula occludes or macula dhaemns. TEM, ×6000 
nephrosis was frequently observed (Fig. 2), uremia being 
the main cause of death. No hematogenous dissemina- 
tion, particularly to the liver or lungs, was found. His- 
tological examination of the tumor specimens revealed 
tumor cells characteristic of a poorly differentiated 
transitional cell carcinoma of the bladder, which 
demonstrated greater variability in both nuclear size and 
shape. The transplanted tumors were histologically 
identical to the original MBT-2 tumors. 
Electron microscopy 
The transplanted tumors showed a comparatively clear 
cytoplasm. Mitochondria were abundant and spherical, 
and showed vestigial cristae. Both rough- and smooth- 
surfaced endoplasmic reticulum was seen in quite long 
stretches. The Golgi apparatus was well developed, with 
large, open lamellae. The nuclei were round, containing 
prominent nucleoli. The nuclear membrane was not re- 
entrant, and there was no margination of chromatin. 
Throughout the tumor, boundaries between cells did not 
show the complex folding seen in the well-differentiated 
tumors and the normal epithelium. The tight junctions 
were poorly formed. The lamina densa of the basement 
membrane was markedly thickened and multilayered (Fig. 3). 
Flow cytometry 
The DNA index (DI) of MBT-2 cells and the trans- 
planted tumor cells was 1.98 and 1.96, respectively, 
which meant hat tumors were tetraploid, and that DNA 
histograms from these primary tumors and transplanted 
tumors were identical. 
Discussion 
The techniques of inducing urothelial tumor by oral 
carcinogens such as FANFT or by intravesical instilla- 
tion of carcinogens such as MNU in rats have been well 
established. However, these useful models have some 
shortcomings. They usually require a long period for the 
tumor to develop: 10-45 weeks for the FANFT model 
and 12 20 weeks for the MNU model [3, 4]. Further- 
more, the entire urothelium of the induced bladder is 
either hyperplastic or neoplastic, and therefore studies 
comparing the induced tumor with the surrounding 
normal mucosa as well as the mechanisms of tumor 
growth and spreading cannot be performed in these 
models. Nude mice have been used for many years for 
heterotransplantation of human tumors. However, 
studies concerning experimental metastases of human 
tumors using these experimental nimals have been 
limited because metastases seldom develop in nude mice 
when they are grafted with human tumor cells. The ex- 
perimental conditions required for nude mice are very 
strict. It has been reported that only 29% of tumor cell 
lines tested could be successfully used following subcu- 
taneous inoculation in such mice and that metastases of
transplanted tumors are not usually observed by gross 
and microscopic observation; the average survival time 
of the tumor-bearing animals is usually less than 2 weeks 
[8]. Previously we described another model for focal 
bladder carcinoma in rats that had a similar success rate 
to the present study [5]. However, a disadvantage of our 
previous model was a high incidence of calculi due to the 
use of sutures, which may have provided a nucleus for 
the formation of urinary stones. The operation was very 
complicated, and our experiments of grafting bladder 
tumor tissue to bladder of syngenic animals were con- 
sistent with the results of previous tudies [6]; our results 
were reported in a previously published study [5]. 
Moreover, this method has other complications includ- 
ing graft necrosis, with extravasation f urine, graft at- 
rophy and perivesical abscess formation. It is very easy 
to observe the appearance of the tumor in the murine 
flank, but the model does not reflect the characteristics 
of the bladder tumor as an orthotopic tumor model. 
Furthermore treatment of orthotopic tumors would 
seem to be a better method since it takes into consider- 
ation the concentration f antitumor agent in the urine. 
Orthotopic models may be used for evaluation of in- 
travesical therapy as well as for systemic therapeutic 
experiments. It is very important, for intravesical ther- 
apy is the best way to decrease a high recurrence rate of 
bladder cancer. Obviously mice bearing the same tumor 
in the flank are not used for this kind of test. 
Our established model of orthotopic transplantation 
in mice using MBT-2 has the following characteristics: 
(a) the incidence of injection and subsequent growth of 
the transitional tumor cell is 100% in all groups; (b) the 
tumors were found in all bladders as early as 2 weeks 
following tumor implantation into the bladders. The 
time for the tumor development and survival time of the 
animals might be controlled by adjusting the dose of the 
tumor cells implanted. There was a good number-related 
response of the urinary bladder to the MBT-2 cells in- 
jected into the submucosa. It is easy and economical to 
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do the operation. (d) The present study utilized a murine 
transitional cell tumor which closely resembled its hu- 
man counterpart histologically. Early stage orthotopic 
murine bladder tumors produced by an identical number 
of cells were always localized, allowing a comparison of 
the induced tumor with surrounding normal mucosa as 
well as the study of the mechanisms of tumor growth 
and spreading. In addition it is possible to produce and 
to study multifocal tumors using the described tech- 
nique, e) The incidence and depth of the tumor corre- 
lated very well with the time and dose of tumor cells 
implanted. Seven days following the procedure, histo- 
logic examination of the bladder showed that almost all 
the cells were in the submucosa but not in the muscular 
layer. Subsequently, the results of our repetitive xperi- 
ments demonstrated this phenomenon, which is due to 
the anatomical characteristics of the murine bladder 
wall. The submucosal layer is much looser than the 
muscular layer. It is very easy to inject the cells into the 
submucosal layer when the bladder is almost empty. The 
earliest change was simple or orderly hyperplasia fol- 
lowed by nodular and/or papillary and finally invasive 
carcinomas associated with the area of hemorrhage or 
necrosis. The sex of mice does not affect the transplan- 
tation of tumors since cells were not placed transure- 
therally into the bladder. (g) Some complications such as 
retrograde infection and bladder stone might be elimi- 
nated effectively because the technique did not involve 
the bladder cavity. 
There are several technical points which are critical to 
the success of the transplantation. First, it is important 
that the viability is always more than 90% using the 
trypan blue exclusion method. Second, the bladder wall 
should not be perforated in order to avoid injecting the 
tumor cells into the cavity. Third, postoperative pro- 
phylactic antibiotics are essential in preventing infection 
and maintaining the tumor cells. 
We believe that the potential applications of this 
model are numerous. In addition to being of use for 
evaluation of chemotherapeutic agents, regimens, and 
other modalities of treatment of TCC, the model can 
also be used for the study of basic mechanisms of tumor 
growth and the spreading and extrinsic and intrinsic 
factors affecting these processes. 
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